MRNS — Marinus Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $30.34m
- $43.35m
- $30.99m
U.S. STOCKS ON THE MOVE-Norwegian Cruise, Taskus, Vertex Energy
Marinus Pharma slides on deep-discounted $60 mln stock deal
Brief: Marinus Pharmaceuticals Announces Pricing Of $60 Million Public Offering
Brief: Marinus Pharmaceuticals Announces Proposed Public Offering
Brief: Marinus Pharmaceuticals Inc Reports Q3 EPS Of $1.89
Marinus Pharmaceuticals Inc expected to post earnings of 47cents a share - Earnings Preview
Brief: Marinus Pharmaceuticals Announces $32.5 Million Revenue Interest Financing Agreement With Sagard Healthcare Partners
Brief: Marinus Pharmaceuticals To Provide Business Update And Report Third Quarter 2022 Financial Results On November 8, 2022
Brief: Marinus Pharmaceuticals Announces Exercise Of First Contract Option By Biomedical Advanced Research And Development Authority
U.S. RESEARCH ROUNDUP-Goodrx Holdings, Nextnav, Olo
Brief: Marinus Pharmaceuticals Reports Second Quarter 2022 Financial Results
Marinus Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Marinus Pharmaceuticals Inc expected to post a loss of 69 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Honeywell International, Better Therapeutics, JAKKS Pacific
Marinus Pharma rises on U.S. launch of seizure treatment
Brief: Marinus Pharmaceuticals Announces U.S. Commercial Launch Of Ztalmy For Seizures Associated With Cdkl5 Deficiency Disorder
U.S. STOCKS ON THE MOVE-First Republic Bank, Canoo Inc, CytomX Therapeutics Inc
Brief: Marinus Enters Into Asset Purchase Deal With Novo Nordisk
Marinus Pharma rises after $110 mln sale of review voucher